email@email.com
Request a Call
Contact Online
Subscribe |
| Log In
The most widely read newsletter on China's life science industry.
Toggle navigation
Home
Subscribe
Top Stories
Hot Topics
Search
Conferences
Consulting
About Us
Contact Us
You are here:
All Products
Articles
Instant access to selected
ChinaBio® Today
subscriber-only articles.
Browse
All Products
Articles
Viewing
256 - 270
of 3630 products
View All
Previous
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
32
33
34
35
36
37
38
39
40
41
42
43
44
45
46
47
48
49
50
51
52
53
54
55
56
57
58
59
60
61
62
63
64
65
66
67
68
69
70
71
72
73
74
75
76
77
78
79
80
81
82
83
84
85
86
87
88
89
90
91
92
93
94
95
96
97
98
99
100
101
102
103
104
105
106
107
108
109
110
111
112
113
114
115
116
117
118
119
120
121
122
123
124
125
126
127
128
129
130
131
132
133
134
135
136
137
138
139
140
141
142
143
144
145
146
147
148
149
150
151
152
153
154
155
156
157
158
159
160
161
162
163
164
165
166
167
168
169
170
171
172
173
174
175
176
177
178
179
180
181
182
183
184
185
186
187
188
189
190
191
192
193
194
195
196
197
198
199
200
201
202
203
204
205
206
207
208
209
210
211
212
213
214
215
216
217
218
219
220
221
222
223
224
225
226
227
228
229
230
231
232
233
234
235
236
237
238
239
240
241
242
Next
Gracell Reports 100% Minimal Residual Disease Rate for CAR-T in Myeloma Trial
$5.00
Available
Ascletis Enrolls 120 Patients for Phase III Trial of Glioblastoma Candidate
$5.00
Available
Elpiscience Starts Australian Trial of Anti-Immunosuppressive Candidate
$5.00
Available
I-Mab Says AbbVie Returns Rights for CD47, Ending $2 Billion Partnership
$5.00
Available
Qihan Biotech Raises $16 Million for Gene-Edited Stem Cell Products
$5.00
Available
Chime Enters Cooperation with Panolos to Develop Multi-Specific Candidate
$5.00
Available
Tonghua Dongbao Out-Licenses US Rights for Three Insulin Biosimilars to Meitheal
$5.00
Available
Everest Acquires China Rights to Lupus Nephritis Candidate in $132 Million Agreement
$5.00
Available
Lynk Closes $16 Million C2 Round to Advance JAK Inhibitors for Autoimmune Diseases
$5.00
Available
AffaMed Begins China Phase III Trial of Therapy for Cataract Surgery Pain
$5.00
Available
Novartis Ends $2.2 Billion Global PD-1 Partnership with BeiGene
$5.00
Available
PackGene and Kudo Bio Partner to Provide End-to-End mRNA Services
$5.00
Available
Canton Biologics Raises $41 Million in C Round for Biologic CDMO Services
$5.00
Available
Clover Biopharma Starts China Distribution of Quadrivalent Seasonal Flu Vaccine
$5.00
Available
Cure Genetics to Develop AAV Vectors for Neuro Startup in $60 Million Deal
$5.00
Available